GURUFOCUS.COM » STOCK LIST » Technology » Software » Synopsys Inc (NAS:SNPS) » Definitions » Cash Flow from Investing

Synopsys (Synopsys) Cash Flow from Investing : $-500 Mil (TTM As of Jan. 2024)


View and export this data going back to 1992. Start your Free Trial

What is Synopsys Cash Flow from Investing?

Cash Flow from Investing covers the cash a company gains or spends from investment activities in financial market and operating subsidiaries. It also includes the cash the company used for property, plant and equipment (PPE).

For the three months ended in Jan. 2024, Synopsys spent $40 Mil on purchasing property, plant, equipment. It gained $0 Mil from selling property, plant, and equipment. It spent $68 Mil on purchasing business. It gained $0 Mil from selling business. It spent $26 Mil on purchasing investments. It gained $80 Mil from selling investments. It paid $0Mil for net Intangibles purchase and sale. And it paid $0 Mil for other investing activities. In all, Synopsys spent $54 Mil on investment activities in financial market and operating subsidiaries for the three months ended in Jan. 2024.


Synopsys Cash Flow from Investing Historical Data

The historical data trend for Synopsys's Cash Flow from Investing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Synopsys Cash Flow from Investing Chart

Synopsys Annual Data
Trend Oct14 Oct15 Oct16 Oct17 Oct18 Oct19 Oct20 Oct21 Oct22 Oct23
Cash Flow from Investing
Get a 7-Day Free Trial Premium Member Only Premium Member Only -235.88 -360.42 -549.03 -572.62 -482.10

Synopsys Quarterly Data
Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24
Cash Flow from Investing Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -36.25 -91.47 -53.84 -300.55 -54.40

Synopsys Cash Flow from Investing Calculation

Cash Flow from Investing covers the cash a company gains or spends from investment activities in financial market and operating subsidiaries. It also includes the cash the company used for property, plant and equipment (PPE).

If a company spends cash on property, plant and equipment (PPE), this will reduce their cash position. This is called Capital Expenditures (CPEX).

Likewise, if a company buys another company for cash, this will reduce their cash position.

Synopsys's Cash Flow from Investing for the fiscal year that ended in Oct. 2023 is calculated as:

Synopsys's Cash Flow from Investing for the quarter that ended in Jan. 2024 is calculated as:


Cash Flow from Investing for the trailing twelve months (TTM) ended in Jan. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-500 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Synopsys  (NAS:SNPS) Cash Flow from Investing Explanation

Cash flow from investing contains nine items:

1. Purchase Of Property, Plant, Equipment:
Purchase of PPE indicates the amount used to purchase property, plant, and equipment.

Synopsys's purchase of property, plant, equipment for the three months ended in Jan. 2024 was $-40 Mil. It means Synopsys spent $40 Mil on purchasing property, plant, equipment.

In the capital spending for property, plant and equipment (PPE), some part of spending may be from the expansion of business. The business needs more property, plant and equipment (PPE) as it grows. Another part may be from replacement of the property, plant and equipment (PPE) of existing business. For some companies, the cash spent on replacing of the property, plant and equipment (PPE) of the existing business will be close to the depreciation of property, plant and equipment (PPE) reported in the income statement.

In Warren Buffett's definition of Owner's Earnings, he deducts the estimate of the cost of replacing the property, plant and equipment (PPE) of the existing business from cash flow from operations. The cash spent on the new property, plant, and equipment is not deducted. The reason is because these are not costs of the existing business. In his 1986 letter to shareholders, Warren Buffett wrote this about owner earnings:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume....Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

2. Sale Of Property, Plant, Equipment:
Sale of PPE indicates the amount gained from selling property, plant, and equipment.

Synopsys's sale of property, plant, equipment for the three months ended in Jan. 2024 was $0 Mil. It means Synopsys gained $0 Mil from selling property, plant, and equipment.

3.Purchase Of Business:
Purchase of business indicates the amount used to purchase business.

Synopsys's purchase of business for the three months ended in Jan. 2024 was $-68 Mil. It means Synopsys spent $68 Mil on purchasing business.

4. Sale Of Business:
Sale of business indicates the amount gained from selling business.

Synopsys's sale of business for the three months ended in Jan. 2024 was $0 Mil. It means Synopsys gained $0 Mil from selling business.

5. Purchase Of Investment:
Purchase of Investments represents cash outflow on the purchase of investments in securities.

Synopsys's purchase of investment for the three months ended in Jan. 2024 was $-26 Mil. It means Synopsys spent {stock_data.stock.currency_symbol}}26 Mil on purchasing investments.

6. Sale Of Investment:
Sale of Investments represents cash inflow on the sale of investments in securities.

Synopsys's sale of investment for the three months ended in Jan. 2024 was $80 Mil. It means Synopsys gained $80 Mil from selling investments.

7. Net Intangibles Purchase And Sale:
Net Intangibles purchase and sale means the net cash inflow received by a company that comes from the purchase and sale of intangibles. It equals the cash received from sale of intangibles minus the cash spent on purchasing intangibles.

Synopsys's net Intangibles purchase and sale for the three months ended in Jan. 2024 was $0 Mil. It means Synopsys paid $0 Mil for net Intangibles purchase and sale.

8. Cash From Discontinued Investing Activities:
Cash from discontinued investing activities means the cash received by a company that comes from the discontinued investing activities.

Synopsys's cash from discontinued investing activities for the three months ended in Jan. 2024 was 0 Mil. It means Synopsys paid $0 Mil for discontinued investing activities.

9. Cash From Other Investing Activities:
Cash from other investing activities means the cash received by a company that comes from other investing activities.

Synopsys's cash from other investing activities for the three months ended in Jan. 2024 was $0 Mil. It means Synopsys paid $0 Mil for other investing activities.


Synopsys Cash Flow from Investing Related Terms

Thank you for viewing the detailed overview of Synopsys's Cash Flow from Investing provided by GuruFocus.com. Please click on the following links to see related term pages.


Synopsys (Synopsys) Business Description

Industry
Address
675 Almanor Avenue, Sunnyvale, CA, USA, 94085
Synopsys is a provider of electronic design automation software, intellectual property, and software integrity products. EDA software automates the chip design process, enhancing design accuracy, productivity, and complexity in a full-flow end-to-end solution. The firm's growing SI business allows customers to continuously manage and test the code base for security and quality. Synopsys' comprehensive portfolio is benefiting from a mutual convergence of semiconductor companies moving up-stack toward systems-like companies, and systems companies moving down-stack toward in-house chip design. The resulting expansion in EDA customers alongside secular digitalization of various end markets benefits EDA vendors like Synopsys.
Executives
Mercedes Johnson director MICRON TECHNOLOGY, INC, 8000 S FEDERAL WAY, MS 1-557, BOISE ID 83716
Richard S. Mahoney officer: Chief Revenue Officer 2600 ANSYS DRIVE, CANONSBURG PA 15317
Runkel John F Jr officer: General Counsel & C/O INTUITIVE SURGICAL, INC., 1266 KIFER ROAD, SUNNYVALE CA 94086
Sudhindra Kankanwadi officer: VP and Corporate Controller 690 E MIDDLEFIELD ROAD, MOUNTAIN VIEW CA 94043
Robert G Painter director C/O TRIMBLE INC., 935 STEWART DRIVE, SUNNYVALE CA 94085
Geus Aart De director, officer: Chairman of the Board & Co-CEO
Sassine Ghazi officer: Chief Operating Officer 3075 W RAY ROAD, SUITE 528, THE PARK AT SAN TAN, CHANDLER AZ 85226
Shelagh Glaser officer: CFO ZENDESK, INC., 989 MARKET STREET, SAN FRANCISCO CA 94103
Roy Vallee director 2211 S 47TH ST, PHOENIX AZ 85034
Joseph W Logan officer: EVP, Sales & Corp Marketing 700 EAST MIDDLEFIELD ROAD, MOUNTAIN VIEW CA 94043
Chrysostomos L Nikias director UNIVERSITY OF SOUTHERN CALIFORNIA, 3551 TROUSEDALE, BOVARD ADM 102, LOS ANGELES CA 90089-4019
Trac Pham officer: CFO 700 E. MIDDLEFIELD ROAD, MOUNTAIN VIEW CA 94043
Luis Borgen director 58 SUNSET RIDGE LANE, BOLTON MA 01740
Marc N Casper director C/O THERMO FISHER SCIENTIFIC, 168 THIRD AVENUE, WALTHAM MA 02451
Chi-foon Chan director, officer: Co-CEO & President